View Item 

Show simple item record

Targeted Gene Transfer for Adenocarcinoma Using a Combination of Tumor-specific Antibody and Tissue-specific Promoter
dc.contributor.authorKurane, Shujien_US
dc.contributor.authorKrauss, John C.en_US
dc.contributor.authorWatari, Eijien_US
dc.contributor.authorKannagi, Reijien_US
dc.contributor.authorChang, Alfred E.en_US
dc.contributor.authorKudoh, Shojien_US
dc.date.accessioned2010-06-01T22:19:03Z
dc.date.available2010-06-01T22:19:03Z
dc.date.issued1998-11en_US
dc.identifier.citationKurane, Shuji; Krauss, John C.; Watari, Eiji; Kannagi, Reiji; Chang, Alfred E.; Kudoh, Shoji (1998). "Targeted Gene Transfer for Adenocarcinoma Using a Combination of Tumor-specific Antibody and Tissue-specific Promoter." Cancer Science 89(11): 1212-1219. <http://hdl.handle.net/2027.42/75328>en_US
dc.identifier.issn1347-9032en_US
dc.identifier.issn1349-7006en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/75328
dc.format.extent122336 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rightsJapanese Cancer Association 1998en_US
dc.subject.otherAnti-Lewis Y Antigen Antibodyen_US
dc.subject.otherCEA Promoteren_US
dc.subject.otherCVM Enhanceren_US
dc.subject.otherCationic Liposomeen_US
dc.subject.otherTumor-specific Gene Expressionen_US
dc.titleTargeted Gene Transfer for Adenocarcinoma Using a Combination of Tumor-specific Antibody and Tissue-specific Promoteren_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Surgical Oncology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, Michigan 48109en_US
dc.contributor.affiliationotherFourth Department of Internal Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8602en_US
dc.contributor.affiliationotherDepartment of Microbiology and Immunology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8602en_US
dc.contributor.affiliationotherCleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, Ohio 441959en_US
dc.contributor.affiliationotherLaboratory of Experimental Pathology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-0012en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/75328/1/j.1349-7006.1998.tb00517.x.pdf
dc.identifier.doi10.1111/j.1349-7006.1998.tb00517.xen_US
dc.identifier.sourceCancer Scienceen_US
dc.identifier.citedreferenceSikorska, H., Shuster, J. and Gold, P. Clinical applications of carcinoembryonic antigen. Can. Detect. Prev., 12, 321 – 355 ( 1988 ).en_US
dc.identifier.citedreferenceShinkai, T., Saijo, N., Tominaga, K., Eguchi, K., Shimizu, E., Sasaki, Y., Fujita, J., Futami, H., Ohkura, H. and Suemasu, K. Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapy. Cancer, 57, 1318 – 1323 ( 1986 ).en_US
dc.identifier.citedreferenceSchrewe, H., Thompson, J., Bona, M., Hefta, L. J. F., Maruya, A., Hassauer, M., Shivel, J. E., Kleist, S. V. and Zimmermann, W. Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression. Mol. Cell. Biol., 10, 2738 – 2748 ( 1990 ).en_US
dc.identifier.citedreferenceOsaki, T., Tanio, Y., Tachibana, I., Hosoe, S., Kumagai, T., Kawase, I., Oikawa, S. and Kishimoto, T. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res., 54, 5258 – 5261 ( 1994 ).en_US
dc.identifier.citedreferenceTanaka, T., Kanai, F., Okabe, S., Yoshida, Y., Wakimoto, H., Hamada, H., Shiratori, Y., Lan, K.-H., Ishitobi, M. and Omata, M. Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric cells in vitro. Cancer Res., 56, 1341 – 1345 ( 1996 ).en_US
dc.identifier.citedreferenceBoshart, M., Weber, F., Jahn, G., Dorsch-Hasler, K., Fleckenstein, B. and Schaffner, W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell, 41, 521 – 530 ( 1985 ).en_US
dc.identifier.citedreferenceTrubetskoy, V. S., Torchilin, V. P., Kennel, S. and Huang, L. Use of N-terminal modified poly (l-lysine)-antibody conjugate as a carrier for targeted gene delivery in mouse lung endothelial cells. Bioconjug. Chem., 3, 323 – 327 ( 1992 ).en_US
dc.identifier.citedreferenceMerwin, J. R., Carmichael, E. P., Noell, G. S., DeRome, M. E., Thomas, W. L., Robert, N., Spitalny, G. and Chiou, H. C. CD5-mediated specific delivery of DNA to T lymphocytes: compartmentalization augmented by adenovirus. J. Immunol. Methods, 186, 257 – 266 ( 1995 ).en_US
dc.identifier.citedreferenceShimizu, N., Chen, J., Gamou, S. and Takayanagi, A. Immunogene approach toward cancer therapy using erythrocyte growth factor receptor-mediated gene delivery. Cancer Gene Ther., 3, 113 – 120 ( 1996 ).en_US
dc.identifier.citedreferenceKaneko, T., Iba, Y., Zenita, K., Shigeta, K., Nakano, K., Itoh, W., Kurosawa, Y., Kannagi, R. and Yasukawa, K. Preparation of mouse-human chimeric antibody to an embryonic carbohydrate antigen, Lewis Y. J. Biochem., 113, 114 – 117 ( 1993 ).en_US
dc.identifier.citedreferenceBlaszczyk-Thurin, M., Thurin, J., Hindsgaul, O., Karlsson, K., Steplewski, Z. and Koprowski, H. Y and blood B type 2 glycolipid antigen accumulate in a human gastric carcinoma cell line as detected by monoclonal antibody. J. Biol. Chem., 262, 372 – 379 ( 1987 ).en_US
dc.identifier.citedreferenceSteplewski, Z., Blaszczyk-Thurin, M., Lubeck, M., Loibner, H., Scholz, D. and Koprowski, H. Oligosaccharide Y specific monoclonal antibody and its isotype switch variants. Hybridoma, 9, 201 – 210 ( 1990 ).en_US
dc.identifier.citedreferenceHirashima, K., Zenita, K., Takada, A., Kitahara, A., Ishihara, G., Harada, R., Ohmori, K., Hirohashi, S., Kyoizumi, S., Akiyama, M. and Kannagi, R. High idiotypic connectivity of the VH7183-encoded antibodies directed to a murine embryonic carbohydrate antigen, Lewis Y, as ascertained by syngeneic anti-idiotype monoclonal antibodies. J. Immunol., 145, 224 – 232 ( 1990 ).en_US
dc.identifier.citedreferenceKrauss, J. C., Mayo-Bond, L. A., Rogers, C. E., Weber, K. E., Todd, R. F. and Wilson, J. M. An in vivo animal model of gene therapy for leukocyte adhesion deficiency. J. Clin. Invest., 88, 1412 – 1417 ( 1991 ).en_US
dc.identifier.citedreferenceWagner, E., Zenke, M., Cotten, M., Beug, H. and Birnstiel, M. L. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc. Natl. Acad. Sci. USA, 87, 3410 – 3414 ( 1990 ).en_US
dc.identifier.citedreferenceBuschle, M., Cotten, M., Kirlappos, H., Mechtler, K., Schaffer, G., Zauner, W., Birnstiel, M. X. and Wager, A. Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex. Hum. Gene Ther., 6, 753 – 761 ( 1995 ).en_US
dc.identifier.citedreferenceRichards, C. A., Austin, E. A. and Huber, B. E. Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumorspecific gene therapy. Hum. Gene Ther., 6, 881 – 893 ( 1995 ).en_US
dc.identifier.citedreferenceVile, R. G. and Hart, I. R. In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res., 53, 962 – 967 ( 1993 ).en_US
dc.identifier.citedreferenceVile, R. G., Nelson, J. A., Castleden, S., Chong, H. and Hart, I. R. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res., 54, 6228 – 6234 ( 1994 ).en_US
dc.identifier.citedreferenceHuber, B. E., Richards, C. A. and Krenitsky, T. A. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc. Natl. Acad. Sci. USA, 88, 8039 – 8043 ( 1991 ).en_US
dc.identifier.citedreferenceWu, G. Y., Wilson, J. M., Shalaby, F., Grossman, M., Shafritz, D. A. and Wu, C. H. Receptor-mediated gene delivery in vivo. J. Biol. Chem., 266, 14338 – 14342 ( 1991 ).en_US
dc.identifier.citedreferenceColl, J.-L., Wagner, E., Metchler, K., Amstutz, H., Iacono-Di-Cacito, I., Simon, N. and Favrot, M. C. In vitro targeting and specific transfection of human neuroblastoma cells by chCE7 antibody-mediated gene transfer. Gene Ther., 4, 156 – 161 ( 1997 ).en_US
dc.identifier.citedreferenceKannagi, R., Nudelman, E., Levery, S. B. and Hakomori, S. A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen, SSEA-1. J. Biol. Chem., 257, 14865 – 14874 ( 1982 ).en_US
dc.identifier.citedreferenceStahel, R. A., Lacroix, H., Sculier, J. P., Morant, R., Richner, J., Janzek, E., Loibner, H. and Blythman, H. Phase I/II study of monoclonal antibody against Lewis Y hapten in relapsed small-cell lung cancer. Ann. Oncol., 3, 319 – 320 ( 1992 ).en_US
dc.identifier.citedreferenceCo, M. S., Baker, J., Bednarik, K., Janzek, E., Neruda, W., Mayer, P., Plot, R., Stumper, B., Vasquez, M., Queen, C. and Loibner, H. Humanized anti-Lewis Y antibodies: in vitro properties and pharmacokinetics in Rhesus monkeys. Cancer Res., 56, 1118 – 1125 ( 1996 ).en_US
dc.identifier.citedreferencePai, L. H., Wittes, R., Setser, A., Willingham, M. C. and Pastan, I. Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin. Nat. Med., 2, 350 – 353 ( 1996 ).en_US
dc.identifier.citedreferenceSjÖgren, H. O., Isaksson, M., Willner, D., HillstrÖm, I., Hellstrom, K. E. and Trail, P. A. Antitumor activity of carcinoma-reactive BR96-Doxorubicin conjugate against human carcinomas in athymic mice and rats and syngeneic rat carcinoma in immunocompetent rats. Cancer Res., 57, 4530 – 4536 ( 1997 ).en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1349-7006.1998.tb00517.x.pdf
Size:
119.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.